At a glance
ClinicalIndex Comparison RecordN/ACompleted· 110 enrolled
Drug / intervention
RestoreX PTT - 6 months +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Penile Length Restoration in Men With Diabetes Mellitus, Type II
In Brief
A clinical study evaluating RestoreX PTT - 6 months and RestoreX PTT - 3 months for Diabetes Mellitus, Type 2 and Penile Diseases. Completed, enrolled 110 participants across 1 site.
Detailed Summary
The objective of the current study is to evaluate the efficacy of a novel penile traction device in restoring lost penile length in men with type 2 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Penile Diseases
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartNov 2018
First PostedNov 2018
Primary CompletionMar 2021
TodayJul 2026
First PostedNov 28, 2018
Enrollment StartNov 7, 2018
Primary CompletionMar 18, 2021
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 7.6 years ago
Interventions
RestoreX PTT - 6 monthsdevice
Penile traction therapy in straight position for all 6 months.
RestoreX PTT - 3 monthsdevice
Penile traction therapy in straight position for first phase (3 months)